Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • ED attaches Delhi...

    ED attaches Delhi businessman property in Sterling Biotech money laundering case

    Written by Ruby Khatun Khatun Published On 2017-12-26T10:45:10+05:30  |  Updated On 26 Dec 2017 10:45 AM IST
    ED attaches Delhi businessman property in Sterling Biotech money laundering case

    New Delhi: The Enforcement Directorate (ED) on Sunday filed prosecution complaints against Delhi businessman, Gagan Dhawan, and also attached assets worth Rs 1.17 crore in a money laundering case.


    The special Prevention of Money Laundering Act (PMLA) court took cognisance of the prosecution complaint filed before it by the ED in the money laundering case of Rs 5,000-crore bank loan fraud by the Sandesara Group of Companies.


    Following the investigations in the Rs 5,000-crore money laundering case of the Sterling Biotech Group, the ED has provisionally attached a plot owned by Gagan Dhawan in DLF Phase III, Gurgaon, to the extent of Rs 1.17 crore.


    The Central Bureau of Investigation (CBI) had registered an FIR against Nitin Sandesara and Chetan Sandesara, the directors and promoters of Sandesara Group of companies, and others for obtaining fraudulent loans from various public sector banks and subsequently diverting and misusing such loans for personal use.


    Read also: CBI FIR against Sterling Biotech for Rs 5,000 cr loan default

    Dhawan reportedly facilitated Nitin and Chetan in diversion and misuse of bank loans obtained by their companies from various public sector banks on the basis of forged and fabricated documents.


    The ED investigations revealed that Dhawan purchased a plot in DLF Phase III, Gurgaon, as loan from PMT Machines Ltd (a Sandesara Group company) which was sourced from the funds obtained from a public sector bank.


    Dhawan was arrested by the ED on November 1 for his role in assisting and facilitating the Sandesaras in money laundering.


    The ED is also probing the case regarding bribing of Income Tax (IT) officials by the Sandesaras and the role of Dhawan in facilitating the same.


    The role of more than 300 Benami entities controlled by the Sandesara Group is also under the ED scanner.


    Further investigation is under process.


    Read also: Sterling Biotech Case: Court asks ED reply on Gagan Dhawan bail plea
    bank loan fraudchargesheetcomplaintsDelhi businessmanEDEnforcement DirectoratefilesGagan Dhawaninvestigationsmoney laundering casePMLAPrevention of Money Laundering ActprosecutionSandesara Group of CompaniesSterling Biotech
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok